Literature DB >> 17441009

Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample.

Nelly Alia-Klein1, Thomas M O'Rourke, Rita Z Goldstein, Dolores Malaspina.   

Abstract

Violence towards others by a minority of psychotic individuals is a significant public health concern. The severity of this other-directed violence (ODV) in the community may be influenced by insight into illness and adherence to psychotropic medications; however, few studies have tested these associations. Sixty male psychotic inpatients, legally detained at a forensic unit in New York City, were assessed with semi-structured interviews, supplemented with information from hospital and official records, family members and the treating clinician. Results indicated that in this unique sample of detained persons with psychotic disorders; (1) increase in the severity of community violence is associated with medication non-adherence, all dimensions of poor insight into illness, and several previously reported covariates such as substance use comorbidity; (2) no relationship was found between insight and adherence in this particular sample; (3) multivariate analyses showed that select covariates, along with medication adherence, and select insight domains predicted a total of 73% of the magnitude of ODV behavior in this sample. Overall, medication non-adherence explained a large amount of how violently participants behaved toward others. Since non-adherence was independent of poor insight, it may be more worthwhile for clinicians to develop treatment strategies to target medication adherence without directly addressing an elusive target such as insight into illness. Treatment addressing medication adherence needs to concomitantly target substance use behaviors since the latter was responsible for a substantial increase in ODV. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17441009     DOI: 10.1002/ab.20170

Source DB:  PubMed          Journal:  Aggress Behav        ISSN: 0096-140X            Impact factor:   2.917


  19 in total

1.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

2.  [Insight and Violent Behavior in a Cohort of Early Psychosis Patients].

Authors:  Valerie Moulin; Julie Palix; Luis Alameda; M Mehdi Gholamrezaee; Philipp S Baumann; Jacques Gasser; Julien Elowe; Alessandra Solida; Philippe Conus
Journal:  Can J Psychiatry       Date:  2017-06-28       Impact factor: 4.356

3.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

Review 4.  Pathways to aggression in schizophrenia affect results of treatment.

Authors:  Jan Volavka; Leslie Citrome
Journal:  Schizophr Bull       Date:  2011-05-11       Impact factor: 9.306

Review 5.  Structured assessment of violence risk in schizophrenia and other psychiatric disorders: a systematic review of the validity, reliability, and item content of 10 available instruments.

Authors:  Jay P Singh; Mark Serper; Jonathan Reinharth; Seena Fazel
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Stigma and violence: isn't it time to connect the dots?

Authors:  E Fuller Torrey
Journal:  Schizophr Bull       Date:  2011-06-07       Impact factor: 9.306

Review 7.  Pharmacological management of acute and persistent aggression in forensic psychiatry settings.

Authors:  Leslie Citrome; Jan Volavka
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

8.  Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies.

Authors:  J Volavka; R A Van Dorn; L Citrome; R S Kahn; W W Fleischhacker; P Czobor
Journal:  Eur Psychiatry       Date:  2015-12-04       Impact factor: 5.361

Review 9.  From Clozapine to Cognitive Remediation.

Authors:  Jason Quinn; Nathan J Kolla
Journal:  Can J Psychiatry       Date:  2016-07-10       Impact factor: 4.356

10.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.